Exodus Point Capital Management, LP A Tyr Pharma Inc Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 19, 2022	SELL	$2.63 - $5.61 $35,389 - $75,488	-13,456 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.75 - $7.54 $63,916 - $101,458	13,456 New	13,456 $72,000
Q2 2021 Aug 16, 2021	SELL	$3.62 - $4.88 $40,058 - $54,002	-11,066 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.53 - $8.06 $39,062 - $89,191	11,066 New	11,066 $49,000

33.5M

7.5K

3.2K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $43.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.